معرفی
Dr. Theodore Karrison is a Professor in the Department of Public Health Sciences at the University of Chicago. He serves as Director of the Biostatistics Laboratory and Technical Director of the Biostatistics Core for the Comprehensive Cancer Center. His work focuses on clinical trial design, oncology research, and survival analysis methodologies. Dr. Karrison has contributed to pivotal studies in areas such as genitourinary cancers, phase II trial endpoints, and response-adaptive designs.
Education: B.S. in Mathematics & Computer Science (University of Illinois at Chicago, 1974), M.S. and Ph.D. in Statistics (University of Chicago, 1975 and 1985).
Research Interests: Development of statistical methods for clinical trials, restricted mean survival analysis, and collaborative oncology studies. Notable contributions include estimating insulin secretion rates, analyzing aneurysm rupture risks, and designing phase II cancer trials.
Current Projects: Leading statistical work for NRG Oncology genitourinary trials, validating metformin in ovarian cancer, and studying azithromycin's effects on asthma microbiomes. Collaborates with multiple institutions on trial design and data analysis.
Grants & Labs: Principal investigator on NIH-funded studies including cancer center support grants and early therapeutics development projects. Oversees Biostatistics Core operations supporting over 200 investigators.
